Oral Cancer Drug Xeloda Receives Positive Opinion From The European Authorities For The Treatment Of Advanced Gastric Cancer

Mon, 26 Feb 2007 02:00 PM EST

... Stomach cancer is the second leading cause of cancer-related deaths worldwide.1Roche announced today that its innovative oral cancer drug Xeloda (capecitabine), in combination with platinum-based chemotherapy, has received a positive recommendation from the European Committee for Medicinal Products for Human Use (CHMP) for first-line use in patients with advanced gastric (stomach) cancer. [click link for full article] ...